BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors

...BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, toda...
Read Full Article